Aktie A2APXB ZENITH CAPITAL CORP.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Zenith Capital Corp.

Aktien

A2APXB

CA98935N1033

ZHCLF

Markt geschlossen - OTC Markets
Andere Börsenplätze
 19:10:50 01.05.2024 		% 5 Tage % 1. Jan.
0.1 USD -60.00% Intraday Chart für Zenith Capital Corp. -50.00% -16.67%
05.04. Zenith Capital Corp. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 31. Januar 2024 CI
2023 Zenith Capital Corp. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 31. Oktober 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Zenith Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024
Zenith Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023
Zenith Capital Corp. Reports Earnings Results for the First Quarter Ended July 31, 2023
Zenith Capital Corp. Reports Earnings Results for the Full Year Ended April 30, 2023
Zenith's Bet Inhibitor ZEN-3694 Providing Significant Clinical Benefit in Patients with Aggressive Cancer Type
Zenith Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023
Zenith Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022
Zenith Capital Corp. Reports Earnings Results for the First Quarter Ended July 31, 2022
Zenith Capital Corp. Auditor Raises 'Going Concern' Doubt
Zenith Capital Corp. Reports Earnings Results for the Full Year Ended April 30, 2022
Zenith Epigenetics Announces Initiation of Phase 2b Triple Negative Breast Cancer Clinical Trial
Zenith Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2022
Zenith Epigenetics Provides Clinical Update
Zenith Epigenetics Announces Changes to Board of Directors
Zenith Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2021
Newsoara BioPharma Co., Ltd. announced that it expects to receive $1.5 million in funding from Zenith Capital Corp.
Zenith Capital Corp. Reports Earnings Results for the Full Year Ended April 30, 2021
Zenith Capital Corp. Auditor Raises 'Going Concern' Doubt
Zenith Epigenetics Announces a Publication Highlighting the Role of ZEN-3694 in Overcoming Resistance to Therapies in Metastatic Castration-Resistant Prostate Cancer
Zenith Epigenetics Announces Clinical Collaboration with Astellas
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2APXB Aktie
  4. Nachrichten Zenith Capital Corp.
  5. Andere Sprachen